NLARx In the News
Statement of NLARx Director Sharon Treat on the "Physician Payments
Sunshine Act" More
Stateside Dispatch on Rx Policy Options Features NLARx Members and Staff More
|
In the States
IOWA: Bill to Will Allow Small Businesses, Others To Buy Into State Program More
WASHINGTON: House Bill Aims to Close Prescription Data Loophole More
RHODE ISLAND: Rhode Island Lawmakers Debate Gov. Carcieri's 'Global Medicaid Waiver' More
MASSACHUSETTS: State Cuts Copayment Assistance Program For Seniors More |
Outrage of the Week
GAO Calls FDA a 'High-Risk' Problem More
|
Fraud & Abuse
Pfizer to Pay Record-Settling $2.3 Billion Fine for Off-Label Promotion of Bextra More
Eli Lilly Expected To Agree to $1.4 Billion Settlement Over Zyprexa More
Lilly to Pay Biggest Fine Ever in Zyprexa Probe More
Former Purdue Execs Excluded from Doing Business With Feds More
Rite Aid Agrees to Pay $5 Million in
Civil Penalties to Resolve Violations in Eight States More
Pharmacy Alleges Schering Inflated Prices
For Medicaid, While Others Paid Much Less More
|
Prices and Access to Healthcare
One in Seven U.S. Residents Younger Than 65 Went Without Prescribed Drugs in 2007 Due to Cost More
Should a Health Fed Decide if a Drug Is Worth the Cost? More
Small stores not scared by big-box drug offers More
Why Medicare Pays So Much for Cancer Drugs More
Employees To Pay Increased Health Insurance Premiums, Deductibles in 2009 More |
Advertising and Marketing
Sunshine Act Reintroduced More
Revised Sunshine Act Deals Pharma Sharp Blow by Eliminating Preemption of State Laws More
Disclosure Follows Sunshine Act Introduction More
Are State's Gift Rules Too Strict? More
New Rules on Doctors and Medical Firms Amid Ethics Concerns More
ePrescribing Opens Up a World of Opportunity for Pharma Marketing More
Let's Focus on Effectiveness, Not Dollars Spent as a Measure of DTC Success More
New Media, Old Regulations: Like Oil and Water, They Don't Mix! More
The HIPAA Paradox: The Privacy Rule That's Not More
|
Conflicts of Interest
OIG Report Finds FDA Oversight of Clinical
Investigators' Financial Disclosures 'Lacking' More
Coming Soon: yourdoctorsfinancialties.com More
|
Pharma Watch
Pfizer in Talks to Buy Wyeth More
Pfizer Agrees to Pay $68 Billion for Rival Wyeth More
Johnson & Johnson Jilted More
Teva And Lonza's Bonding Experience More
Abbott Cuts Sales Reps More
Sales Force Cuts Have Only Just Begun More
|
PBM Watch
Venture-Capital Losses Nick UnitedHealth More
WellNet Healthcare Licenses Drug Comparison Tool More
Wellpoint Ordered Out of Medicare Drug Plan More
|
Medicare
House Dems Bill to Allow Medicare To
Offer Prescription Drug Plans to Compete With Private Plans More
Medicare Closes Off WellPoint's Drug Plan More
Medicare Widens Drugs It Accepts for Cancer More
CMS Releases Rule on Part D Drug Coverage More
PhRMA CEO Tauzin Expresses Opposition to Government Negotiating Medicare Drug Prices More
|
Medicaid
Medicaid Enrollment Surging as Economy Weakens, Employer-Sponsored Health Coverage Declines More
Two House Panels Approve Medicaid, COBRA, Health IT Funding in Economic Stimulus Package More
Pfizer CEO and Stanford Professor Propose Pharma Reimbursement Treaty More
|
Patents and Generics
Poll Shows 81% of US Consumers Would Choose Generic Over Brand Name Drug More
Rep. Emerson Reintroduces Proposal
To Block 'Authorized' Generic Drugs More
Innovation Gridlock More
Just How Tall Is the 'Patent Cliff'? More |
Safety and Clinical Trials
Report Criticizes F.D.A. on Device Testing More
FDA Issues Draft Guidances for Industry
To Improve Safety of Drug Supply Chain More
Acting FDA Chief Promises Science, Not Politics More
Mandatory Medical Disclosure Gains Traction More
FDA Issues Draft Guidances for Industry
To Improve Safety of Drug Supply Chain More
FDA Issues Public Health Advisory
About Dangers of Skin Numbing Products More
Newer Antipsychotic Drugs Double Heart Risk, Just Like Older Meds More
Harvard Medical School to Review Drug Research Ethics More
FDA Needs More Resources to Keep
Drugs Safe, PhRMA President Says More
Keep That 1876 Journal Handy, It Just May Help Treat Diabetes More |
Electronic Records
Panels Back Expansion of Insurance and Electronic Medical Records in Stimulus More
Electronic Prescribing Increases as Medicare, Private Health Plans Offer Incentives More
E-Prescribing: Green Means Generic; Red Means Pricey Brand More
Allscripts CEO Urges One-Two Punch on Electronic Medical Records More
|
Importation
Senators Predict Drug Reimportation Bill
Will Finally Pass Congress This Session More
Federal Agencies Issue Draft Guidance
On Good Importer Practices for Industry More
FDA Launches Voluntary Pilot Program
To Promote Safety of Imported Drugs More
|
